Anthony Quinn Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anthony Quinn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anthony Quinn. Anthony Quinn is a EVP, CMO & Head of R&D in SYNAGEVA BIOPHARMA CORP ($GEVA) and a SVP, Chief Medical Officer in SYNAGEVA BIOPHARMA CORP ($GEVA).
Address: 33 HAYDEN AVE LEXINGTON 02421 MA
Companies in which Anthony Quinn is an Insider
SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Anthony Quinn: EVP, CMO & Head of R&D, SVP, Chief Medical Officer
Holdings: 25,595 shares
Latest Transaction: Sep 04 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Anthony Quinn
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 04 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Option Exercise | M | 23.00 | 10,000 | 230,000 | 30,000 | |
| Sep 04 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Sell | S | 72.88 | 300 | 21,864 | 25,595 | 25.9 K to 25.6 K (-1.16 %) |
| Sep 04 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Sell | S | 71.96 | 700 | 50,372 | 25,895 | 26.6 K to 25.9 K (-2.63 %) |
| Sep 04 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Sell | S | 70.50 | 400 | 28,200 | 26,595 | 27 K to 26.6 K (-1.48 %) |
| Sep 04 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Sell | S | 69.88 | 8,600 | 600,968 | 26,995 | 35.6 K to 27 K (-24.16 %) |
| Sep 04 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Buy | M | 23.00 | 10,000 | 230,000 | 35,595 | 25.6 K to 35.6 K (+39.07 %) |
| Jul 02 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Quinn Anthony | EVP, CMO & Head of ... | Grant | A | 54.89 | 71 | 3,897 | 25,595 | 25.5 K to 25.6 K (+0.28 %) |